Celgene Corporation (NASDAQ:CELG) reported 6/30/2017 earnings this Morning, coming in at $1.82 per share, beating Wall Street’s estimates of $1.61 per Share. Revenue for the quarter came in at $3.27 billion beating analyst estimates of $3.23 billion
Analyst Coverage For Celgene Corporation (NASDAQ:CELG)
These are 1 Sell Rating, 5 Hold Ratings, 20 Buy Ratings .
The current consensus rating for Celgene Corporation (NASDAQ:CELG) is Buy (Score: 2.73) with a consensus target price of $141.27 , a potential (2.55% upside)Recent Insider Trading for Celgene Corporation (NASDAQ:CELG)
- On 6/26/2017 James J Loughlin, Director, sold 18,500 with an average share price of $133.57 per share and the total transaction amounting to $2,471,045.00.
- On 6/22/2017 Michael A Friedman, Director, sold 10,000 with an average share price of $132.50 per share and the total transaction amounting to $1,325,000.00.
- On 6/22/2017 Robert J Hugin, Insider, sold 175,970 with an average share price of $134.14 per share and the total transaction amounting to $23,604,615.80.
- On 6/21/2017 Michael D Casey, Director, sold 9,250 with an average share price of $133.05 per share and the total transaction amounting to $1,230,712.50.
- On 6/19/2017 Michael D. Casey, Director, sold 9,250 with an average share price of $125.59 per share and the total transaction amounting to $1,161,707.50.
- On 6/15/2017 Rupert Vessey, Insider, sold 4,785 with an average share price of $120.18 per share and the total transaction amounting to $575,061.30.
Recent Trading for Celgene Corporation (NASDAQ:CELG) Shares of Celgene Corporation closed the previous trading session at 134.45 down -3.30 -2.40% with 3,281,447 shares trading hands.